Literature DB >> 20125208

[Acute renal failure in critically ill patients].

Jon Henrik Laake1, Jan Fredrik Bugge.   

Abstract

BACKGROUND: Acute renal failure is common in critically ill patients and is associated with a high mortality rate. This paper reviews current management of patients with acute renal failure admitted to an intensive care unit.
MATERIAL AND METHODS: Literature search in databases (Medline, Cochrane database of systematic reviews, UpToDate).
RESULTS: The prevalence of acute renal failure is 5-20 % in patients admitted to intensive care units; the associated hospital mortality is 30-60 %. The aetiology is usually multifactorial; inflammation (sepsis, surgery), hypovolaemia and drug toxicity commonly precipitate acute renal failure. There is no effective drug treatment, but early onset of renal replacement therapies with haemodialysis or haemofiltration is likely to prolong survival.
INTERPRETATION: Despite modern intensive care, mortality is high in acute renal failure and preventive measures should therefore be vigorously pursued. Haemodialysis and haemofiltration should be introduced early in acute renal failure, and should be available in all intensive care units.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125208     DOI: 10.4045/tidsskr.10.34549

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Determining the optimal time for liberation from renal replacement therapy in critically ill patients: protocol for a systematic review and meta-analysis (DOnE RRT).

Authors:  Abdalrhman Al Saadon; Riley Katulka; Meghan Sebastianski; Robin Featherstone; Ben Vandermeer; R T Noel Gibney; Oleksa G Rewa; Sean M Bagshaw
Journal:  BMJ Open       Date:  2018-11-25       Impact factor: 2.692

2.  Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner.

Authors:  Mizuko Ikeda; Thomas Swide; Alexandra Vayl; Tim Lahm; Sharon Anderson; Michael P Hutchens
Journal:  Crit Care       Date:  2015-09-18       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.